Gender dysphoria: Quality of online information for gender reassignment surgery.

JPRAS Open

Department of Surgery ''P.Valdoni'' - Unit of Plastic and Reconstructive Surgery, Policlinico Umberto I, Giovanni Maria Lancisi Street, 2, Rome 00161, Italy.

Published: December 2023

AI Article Synopsis

  • * A study evaluated 20 websites using the EQIP tool and found that the average information quality score was 22.5 out of 36, indicating low quality and insufficient details about procedures and risks.
  • * The findings suggest that most websites offered inadequate information, highlighting the need for professional guidance over Internet resources for patients seeking knowledge about gender reassignment surgery.

Article Abstract

An ever-increasing number of patients are using the Internet to learn about medical conditions. This study aimed to evaluate the quality of Internet-based patient information on gender reassignment surgery for people who suffer from gender dysphoria. Twenty websites identified using Google and Yahoo search engines were selected and evaluated based on the modified Ensuring Quality Information for Patients (EQIP) instrument (36 items). The EQIP tool comprises 36 questions to which the answer can be "yes" or "no". The final score for each website can be between 0 and 36. An overall score of 26 or above was considered high, because it co-related to the 72nd percentile. The average of the scores turned out to be 22.5 points, lower than our target; 7 (35%) sites were rated higher than the average and 13 (65%) were rated lower. The assessment of the websites included in the study showed a lack of information about the sequence of the medical procedures, perioperative criticalities and qualitative risks and side-effects descriptions. The overall quality of published information on gender reassignment surgery is very low. We believe that the Internet should not be used as the main source of medical information, and physicians should maintain the leadership in guiding patients affected by gender dysphoria. Level of Evidence: Level IV, case study.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522961PMC
http://dx.doi.org/10.1016/j.jpra.2023.08.008DOI Listing

Publication Analysis

Top Keywords

gender dysphoria
12
gender reassignment
12
reassignment surgery
12
gender
6
quality
4
dysphoria quality
4
quality online
4
online gender
4
surgery ever-increasing
4
ever-increasing number
4

Similar Publications

This paper critically examines the scientific and ethical underpinnings of gender-affirming care, particularly for minors. While major medical organizations endorse such interventions as medically necessary, the evidence supporting their long-term safety and efficacy remains limited. Research into hormonal, neuroanatomic, and genetic influences reveals a strong biological basis for gender identity, challenging social constructionist arguments.

View Article and Find Full Text PDF

3β-Hydroxysteroid dehydrogenase 2 deficiency (3βHSD2D) is a rare form of congenital adrenal hyperplasia (CAH) with variable clinical presentation. We describe a 46, XY child with ambiguous genitalia and CAH without apparent adrenal insufficiency due to 2 novel heterozygous variants in the gene (c.779C > T/p.

View Article and Find Full Text PDF

[This corrects the article DOI: 10.3389/fendo.2023.

View Article and Find Full Text PDF

There is limited research concerning the transgender population's health issues, such as gender dysphoria, and disparities within the healthcare system, especially in the Latino or Hispanic population. This study aimed to report the case of a Puerto Rican transgender man who achieved pregnancy without reproductive assistance after cessation of testosterone therapy for 3 months and who in the postpartum period experienced significant gender dysphoria. A narrative literature review was carried out to identify the role of gender dysphoria in pregnancy, lactation, health-related spaces, and mental health.

View Article and Find Full Text PDF

A Retrospective Cohort Study of Transgender Adolescents' Gender-Affirming Hormone Discontinuation.

J Adolesc Health

January 2025

Department of Endocrinology, Boston Children's Hospital, Boston, Massachusetts; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.

Purpose: To understand the rate of, and reasons for, discontinuation of gender-affirming hormones (GAH) in transgender adolescents.

Methods: Retrospective cohort study of individuals starting GAH between January 2007 and December 2022. Individuals were included if they were diagnosed with gender dysphoria, were prescribed GAH, and took GAH continuously for a minimum of 6 months.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!